Medical Cannabis Studies

• View All (505)

Strategies for Improving the Lives of Women Aged 40 and Above Living With HIV/AIDS [Internet] (2016)

The objective of this research was to identify and characterize the empirical studies of strategies for the comprehensive treatment of women over 40 years of age or older living with HIV / AIDS. View study
STUDIES INVESTIGATING THE MECHANISMS OF THE CARDIOPROTECTIVE EFFECTS OF CANNABIDIOL (2010)

Heart and circulatory system diseases are generically known as cardiovascular diseases (CVD). This research study focused on better understanding the pharmacology of phytocannabinoid cannabidiol (CBD) by evaluating the hemodynamic responses to CBD and other cannabinoids using rats . View study
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid (2007)

The results obtained give evidence that the addition of ajulemic acid (AjA) (3-30 M) to macrophages derived from human monocytes in vitro reduces the steady state levels of IL-6 mRNA and the subsequent secretion of IL-6 of cells stimulated with LPS View study
Survey Results of Pain Treatments in Adults with Cerebral Palsy (2011)

The objective of this investigation was an analysis of the results made through a survey to examine the perceived effectiveness of pain treatments used by people with cerebral palsy (CP); and identify the types of health care providers that were accessed for pain-related services. View study
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer (2009)

This research was based on the study about the effects and mechanism of action of synthetic non-psychotic cannabinoids on the growth of breast cancer and metastasis. The results indicate that CB1 and CB2 receptors could be used to develop new therapeutic strategies against the growth of breast cancer and metastasis. View study
Synthetic cannabinoids in dementia with agitation: case studies and literature review (2013)

A synthetic cannabinoid known as Nabilone improved psychomotor agitation, aggression and communication in patients with dementia, thus demonstrating the potential of cannabinoids in the treatment of these disorders. View study
Systematic review and meta-analysis of cannabis treatment for chronic pain (2009)

It is evident that cannabis has been used for thousands of years in traditional medicine. Nowadays it has been tried to clarify scientifically which are the beneficial effects and which are the noxious for its therapeutic use, for it has been demonstrated that it is moderately effective in the treatment of the chronic pain. View study
Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas ()

This systematic review of the literature on clinical and experimental trials aimed to evaluate the antitumor effects of cannabinoids on gliomas. View study
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (2016)

The medicinal uses of marijuana have been known for a long time. This research aimed to study the conduction to CB2 cannabinoid receptors as a new therapy to treat malignant lymphoblastic disease. In summary, the results presented here show that activation of the CB2 receptor signals apoptosis through a stimulation dependent on the ceramide of the mitochondrial intrinsic pathway View study
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain (2015)

Cannabis contains the psychoactive component delta9-tetrahydrocannabinol (delta9-THC), and the non-psychoactive components cannabidiol (CBD), cannabinol and cannabigerol. In this review an analysis of the therapeutic possibility of CDB as a cerebroprotective agent will be made, highlighting the recent pharmacological advances, the new mechanisms and the therapeutic time window of the (CBD) in the ischemic stroke. View study
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (2014)

The G protein-coupled receptors CB2 (CB2R) and GPR55 are overexpressed in cancer cells and human tumors. Because a modulation of GPR55 activity by cannabinoids has been suggested, in this investigation an analysis was made on whether this receptor participates in the effects of cannabinoids on cancer cells. View study
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer (2014)

It could be concluded in this review that the development of compounds that can simultaneously attack multiple anti-tumor cannabinoid pathways efficiently can provide a novel approach for the treatment of patients with metastatic breast cancer. View study